Contaminated Needle Lawsuit Filed Against Hospital Over Insulin Shot

A Chicago hospital faces a medical malpractice lawsuit from a woman who alleges that staff used contaminated needles to give her insulin shots, exposing her to a risk of infection with HIV, and hepatitis B and C. 

The complaint was filed against Rush University Medical Center earlier this month in Cook County Circuit Court by Ericka Maciel, according to a report by the Cook County Record.

The lawsuit indicates that Maciel was undergoing treatment at Rush University Medical Center on January 24, 2014, for gluteal abscess and polymicrobial sepsis. Because she has type 1 diabetes, Maciel requires three insulin shots per day. Maciel indicates that she was injected with a contaminated needle by a registered nurse at the hospital, Benjamin Gerlin.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

A year later, on January 25, 2015, the hospital notified Maciel that Gerlin had used the incorrect insulin pen. The pen had previously been used on another patient who was diagnosed with human immunodeficiency virus (HIV), hepatitis B and hepatitis C.

Maciel’s lawsuit against the medical center accuses it of negligence, medical battery, cross contamination of medical equipment, failure to follow medical procedures, and says the incident caused her unnecessary pain and suffering, and loss of enjoyment of normal life.

In August 2010, the FDA and the U.S. Centers for Disease Control and Prevention (CDC) issued a joint safety alert reminding health care workers nationwide not to reuse needles. The reuse of needles is considered by the medical community an event which should never happen and for which there is no reasonable excuse.

Federal health officials say, however, that they have seen a steadily increasing number of blood borne hospital acquired infections over the past 15 to 20 years caused by the reuse of fingersticks, which are small lancets designed to cause a patient’s finger to bleed to get a small blood sample.

The most notable increase has been the spread of Hepatitis B infections in nursing homes, both in long-term care and assisted living settings. However, the increases are present in a wide variety of health care settings.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted yesterday)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 2 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 3 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.